About Crossroad

Crossroad FCP (“Crossroad”) is a top-tier venture capital fund that invests in early-stage Israeli companies with unique intellectual property, exceptional management teams and high potential for market penetrability and growth.

Crossroad focuses mainly on companies that are active in the sectors of Medical Devices, Information & Communication Technology, Renewable Energy, Biotechnology and Pharmaceuticals. The fund seeks to invest where it can add value by utilizing its unique strategic capabilities and multinational network.

Crossroad is an open-ended venture capital fund whose units are listed in the Luxembourg Stock Exchange. The Generali Insurance Group is the fund investor. As of today, the fund has invested more than $100 million in Israeli high-tech startup companies.

Crossroad is managed by ALLEGRO S.à.r.l., an independent management company operating in Luxembourg (http://allegrofunds.com/-Allegro,4-). Specializing in providing high quality services for Specialized Investment Funds, as well as for their management companies. Allegro assumes management and administration for private equity funds, hedge funds, and fund of funds in real estate.

BIT Enterprises Ltd. serves as Crossroad’s investment adviser. Operating from Israel, BIT Enterprises evaluates investment opportunities for the fund using highly-reputable field experts and professionals, and supports portfolio companies in their strategic and business objectives.